MRD / Regn No. : SG000677 Date : 11/07/2026
Patient Name : Keya Halder Age & Gender : 53 Yrs. / Female
Contact No. : 8583063392 UHID :
Ht / Wt / BMI : 149 / 61 / 27.48 BP S / BP D : 168 / 87
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (07/Jan/2013) | HYPERTENSION (07/Jan/2023) |
Salient Investigations : CREATININE: 0.81 | EGFR EGLOMERULAR FILTRATION RATE: 79.21 mL/min/1.73m2 | HBA1C GLYCOSYLATED HEMOGLOBIN: 6.37 %
S# Generic (Trade) Name Route Dosage Usage Duration
1 TELMISARTAN 80 MG + CHLORTHALIDONE 12.5 MG
TELMA CT 		PO 1-0-0 BEFORE DINNER
 TILL NEXT VISIT
2 METOPROLOL 50 MG + AMLODIPINE 5 MG
AMLODAC M 		PO 1-0-1 BEFORE BREAKFAST AND DIINER
 TILL NEXT VISIT
3 TABLET ROSUVASTATIN 10 MG
STATEZE R 		PO 0-0-1 BEFORE DINNER
4 INJECTION GLARGINE (INJ U100)
LANTUS
Medicine For GLUCOSE CONTROL 		SQ 0-0-18 BEDTIME
 TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
5 ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG + LINAGLIPTIN 5 MG
ZEXRIDA L 		PO 1-0-0 BEFORE BREAKFAST
 TILL NEXT VISIT
6 GLIMEPIRIDE 2 MG + METFORMIN 500 MG + PIOGLITAZONE 15 MG
GLIMESTER PM2 		PO 1-0-1 BEFORE BREAKFAST AND DINNER
 TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 11/Jan/2027
Tests Suggested For Next Visit : SMBG,HBA1C-HPLC METHOD,UACR:SPOT SAMPLE,RETINA CHECK UP
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: